Pfizer Inc.’s announcement that that it would be seeking authorization for a booster shot to its COVID vaccine raises a host of challenges for the US government, from what criteria it will use to evaluate the application, to how it will communicate with the public about the issue.
Health officials have long acknowledged the near inevitability of boosters. (Also see "US Gov't Plans To Control COVID Vaccine...